Alpha 2.0
Login Register
» Authors » Charles H Bowden

Charles H Bowden

Explore the profile of Charles H Bowden including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 379
Followers 0
Related Specialties
Urology
General Medicine
Psychiatry
Top 10 Co-Authors
Wesley W Day
Craig A Peterson
Irwin Goldstein
Karen DiDonato
Michael Schwiers
Laurence H Belkoff
LeRoy A Jones
Judd W Moul
Serena Tonstad
Suzanne Oparil
Published In
J Urol
Am J Clin Nutr
Sleep
J Sex Med
Mayo Clin Proc
Affiliations
Soon will be listed here.
Recent Articles
1.
Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study
Hellstrom W, Kaminetsky J, Belkoff L, Goldstein I, Tursi J, Uy J, et al.
J Urol . 2015 Jan; 194(2):485-92. PMID: 25591992
Purpose: We examined the therapeutic effects of avanafil 15 minutes after dosing in men with mild to severe erectile dysfunction. Materials And Methods: This randomized, double-blind, placebo controlled, 12-week study...
2.
Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m(2)
Davidson M, Tonstad S, Oparil S, Schwiers M, Day W, Bowden C
Am J Cardiol . 2013 Feb; 111(8):1131-8. PMID: 23375187
The aim of this analysis was to evaluate changes in cardiovascular risk factors in obese patients with dyslipidemia and/or hypertension receiving phentermine (PHEN) and topiramate extended-release (TPM ER). In the...
3.
A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy
Mulhall J, Burnett A, Wang R, McVary K, Moul J, Bowden C, et al.
J Urol . 2012 Dec; 189(6):2229-36. PMID: 23219537
Purpose: We evaluated the safety and efficacy of 100 and 200 mg avanafil for the treatment of adult males with erectile dysfunction after bilateral nerve sparing radical prostatectomy. Materials And...
4.
A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults
Winslow D, Bowden C, DiDonato K, McCullough P
Sleep . 2012 Nov; 35(11):1529-39. PMID: 23115402
Study Objectives: To evaluate safety and efficacy of phentermine 15 mg plus extended-release topiramate 92 mg for treatment of moderate to severe obstructive sleep apnea (OSA) in obese adults. Design:...
5.
Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus
Goldstein I, Jones L, Belkoff L, Karlin G, Bowden C, Peterson C, et al.
Mayo Clin Proc . 2012 Aug; 87(9):843-52. PMID: 22857780
Objective: To prospectively assess the safety and effectiveness of the investigational phosphodiesterase 5 inhibitor avanafil to treat erectile dysfunction in men with diabetes mellitus. Patients And Methods: This 12-week, multicenter,...
6.
A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction
Goldstein I, McCullough A, Jones L, Hellstrom W, Bowden C, DiDonato K, et al.
J Sex Med . 2012 Jan; 9(4):1122-33. PMID: 22248153
Introduction: Phosphodiesterase type 5 (PDE5) inhibitors have become standard treatment for erectile dysfunction (ED). Aim: To prospectively evaluate the safety and efficacy of avanafil, a novel PDE5 inhibitor, in men...
7.
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Garvey W, Ryan D, Look M, Gadde K, Allison D, Peterson C, et al.
Am J Clin Nutr . 2011 Dec; 95(2):297-308. PMID: 22158731
Background: Obesity is a serious chronic disease. Controlled-release phentermine/topiramate (PHEN/TPM CR), as an adjunct to lifestyle modification, has previously shown significant weight loss compared with placebo in a 56-wk study...